AxiomSL Unveils New Regulatory Solution for Broker-Dealers

The tool addresses SEC rules 17a-5 and 15c3-1.

bruce-runciman-executive-director-of-axiomsl
Bruce Runciman, AxiomSL

While the tool is meant to provide transparency and granularity for calculations and a streamlined reporting process for a multitude of rules, the two most pressing for brokers is the SEC reporting rule 17a-5 and the capital requirement rule 15c3-1.

Bruce Runciman, executive director of AxiomSL, tells Sell-Side Technology that the solution computes "inventory haircuts" by classifying the various inventory positions as to their type, performing a netting function for same positions, performing a

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Europe is counting its vendors—and souring on US tech

Under DORA, every financial company with business in the EU must report use of their critical vendors. Deadlines vary, but the message doesn’t: The EU is taking stock of technology dependencies, especially upon US providers.

The European T+1 effect on Asia

T+1 is coming in Europe, and Asian firms should assess impacts and begin preparations now, says the DTCC’s Val Wotton.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here